IMAX Corporation filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 5, 2026, reporting results for the three and nine months ended on that date.

Key Highlights

  • Nine-month net income attributable to common shareholders: $133,433 thousand, up from $34,239 thousand in the same period of 2025, according to the filing.
  • Third-quarter revenue: $174,552 thousand for the three months ended September 30, 2026, compared with $106,654 thousand in the prior-year quarter.
  • Third-quarter diluted EPS: $1.96 per share, versus $0.37 in Q3 2025, as reported in the filing.
  • Total assets: $1,029,944 thousand as of September 30, 2026, up from $894,031 thousand at December 31, 2025.
  • Goodwill impairment charge: $6,788 thousand recorded in the three and nine months ended September 30, 2026, with no comparable charge in the prior-year periods.
  • Shares outstanding: 55,202,901 common shares as of September 30, 2026, compared with 53,921,676 at December 31, 2025.
  • Income tax recovery: $43,302 thousand tax recovery recorded in Q3 2026, versus a tax expense of $5,205 thousand in Q3 2025.

IMAX Corporation Revenue and Earnings for the Nine Months Ended September 30, 2026

According to the filing, IMAX Corporation (NYSE:IMAX) reported total revenues of $358,773 thousand for the nine months ended September 30, 2026, compared with $285,005 thousand in the same period of 2025. For the third quarter alone, revenues reached $174,552 thousand, up from $106,654 thousand a year earlier. The largest revenue component in the nine-month period was image enhancement and maintenance services at $212,710 thousand, followed by technology rentals at $78,060 thousand and technology sales at $58,944 thousand.

The company disclosed gross margin of $126,302 thousand for Q3 2026 and $235,009 thousand for the nine-month period, compared with $67,271 thousand and $174,049 thousand, respectively, in the prior-year periods. Selling, general and administrative expenses were $106,099 thousand for the nine months ended September 30, 2026, versus $102,983 thousand a year prior. The filing noted a goodwill impairment of $6,788 thousand in Q3 2026 and restructuring charges and other impairments of $2,294 thousand recorded in the nine-month period, with no comparable goodwill impairment charge in 2025. Income from operations for the nine months was $105,601 thousand, compared with $60,125 thousand in the prior-year period.

Net income for the nine months ended September 30, 2026 was $139,058 thousand, of which $133,433 thousand was attributable to common shareholders, translating to diluted earnings per share of $2.35, compared with $0.62 in the nine months ended September 30, 2025. On the balance sheet, total shareholders' equity attributable to common shareholders stood at $491,549 thousand as of September 30, 2026, versus $337,891 thousand at December 31, 2025. Cash and cash equivalents were $207,918 thousand at September 30, 2026, up from $151,168 thousand at year-end 2025. The revolving credit facility showed no outstanding borrowings at September 30, 2026, compared with $34,577 thousand at December 31, 2025.

What Was Disclosed

IMAX Corporation filed its quarterly 10-Q report covering the period ended September 30, 2026, disclosing revenue, earnings, balance sheet data, and a goodwill impairment charge, with 55,202,901 common shares outstanding listed on the New York Stock Exchange.